100728-74-3Relevant articles and documents
-
Baizer et al.
, p. 1276 (1956)
-
Discovery and structure-activity relationship studies of N6-benzoyladenine derivatives as novel BRD4 inhibitors
Noguchi-Yachide, Tomomi,Sakai, Taki,Hashimoto, Yuichi,Yamaguchi, Takao
, p. 953 - 959 (2015/03/04)
Bromodomain and extra-terminal domain (BET) proteins are epigenetic readers that bind to acetylated lysines in histones. Among them, BRD4 is a candidate target molecule of therapeutic agents for diverse diseases, including cancer and inflammatory disease.